Postoperative Radioiodine Treatment within 9 Months from Diagnosis Significantly Reduces the Risk of Relapse in Low-Risk Differentiated Thyroid Carcinoma

PURPOSE: Although postoperative radioiodine (RAI) therapy has been used in patients with differentiated thyroid carcinoma (DTC) for many years, there is still lack of data defining the timing of RAI administration. A retrospective analysis was carried out to answer the question whether the time of p...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Nucl Med Mol Imaging
Glavni autori: Krajewska, Jolanta, Jarzab, Michal, Kukulska, Aleksandra, Czarniecka, Agnieszka, Roskosz, Jozef, Puch, Zbigniew, Wygoda, Zbigniew, Paliczka-Cieslik, Ewa, Kropinska, Aleksandra, Krol, Aleksandra, Handkiewicz-Junak, Daria, Jarzab, Barbara
Format: Artigo
Jezik:Inglês
Izdano: Springer Berlin Heidelberg 2019
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6821904/
https://ncbi.nlm.nih.gov/pubmed/31723361
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13139-019-00608-8
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items